RxCrossroads Licensed to Relabel and Repackage Pharmaceuticals
(Thomson Reuters ONE) -
LOUISVILLE, Ky., April 11, 2013 - Omnicare Specialty Care Group (SCG)'s
RxCrossroads announced it has been licensed by the Food and Drug Administration
(FDA) to relabel and repackage both medical devices and pharmaceuticals.
"We are pleased to offer our customers comprehensive solutions that include
relabeling and repackaging services," said David Hileman, Senior Vice President,
Omnicare Specialty Care Group. "These capabilities not only reduce costs for our
clients, but also offer faster turnaround times and increased safety and
security of product."
Omnicare SCG's RxCrossroads is ISO9001:2008 certified, FDA registered, cGMP
compliant, and DEA licensed in order to provide full order-to-cash logistics
services for the pharma/bio industry. The company's three logistics facilities
accommodate receipt, storage, and distribution of pharmaceutical, biologic and
medical device finished goods products and Active Product Ingredients (API). All
sites are strategically located to key parcel shipping hubs, providing the
ability to reach more than 60 percent of the U.S. population in two business
days through standard ground service.
Omnicare Specialty Care Group's third party logistics platform provides
customized solutions specifically tailored to the biotechnology and
pharmaceutical industries. In addition to these services, integrated solutions
include brand support, reimbursement assistance, direct-to-patient dispensing,
patient education and adherence counseling. The company collaborates with
partners to custom design programs that meet the unique opportunities and
challenges of each individual brand and the healthcare environment.
About Omnicare Specialty Care Group
Omnicare Specialty Care Group (SCG) is a division of Omnicare, Inc., a Fortune
400 company and provider of comprehensive pharmaceutical services based in
Cincinnati, Ohio. Omnicare SCG is a combination of synergistic tenured companies
with a focused approach to pharmaceutical brand solutions. Together, Omnicare
SCG brings specialists in reimbursement methods, clinicians practiced in
medication therapy management for chronic disease states, and distribution
channel expertise. Solutions are tailored to drive product access by solving
challenges faced by patients and their caregivers, physicians, payers and
manufacturers. Custom programs are led by a single management team across the
organizational platforms, allowing coordination of resources and assets to
support positive outcomes for our patients. For more information, visit
www.omnicarescg.com
About Omnicare
Omnicare, Inc., a Fortune 400 company based in Cincinnati, Ohio, provides
comprehensive pharmaceutical services to patients and providers across North
America. As the market-leader in professional pharmacy, related consulting and
data management services for skilled nursing, assisted living and other chronic
care institutions, Omnicare leverages its unparalleled clinical insight into the
geriatric market along with some of the industry's most innovative technological
capabilities to the benefit of its long-term care customers. Omnicare also
provides key commercialization services for the bio-pharmaceutical industry and
end-of-life disease management through its Specialty Care Group. For more
information, visit http://www.omnicare.com/.
# # #
Contact:
Media:
Ed Loyd
(513) 719-0808
ed.loyd(at)omnicare.com
Business:
David Hileman
(502) 213-1104
david.hileman(at)omnicare.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Omnicare via Thomson Reuters ONE
[HUG#1692185]
Unternehmensinformation / Kurzprofil:
Datum: 11.04.2013 - 14:00 Uhr
Sprache: Deutsch
News-ID 248225
Anzahl Zeichen: 4450
contact information:
Town:
Covington, KY
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 207 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"RxCrossroads Licensed to Relabel and Repackage Pharmaceuticals"
steht unter der journalistisch-redaktionellen Verantwortung von
Omnicare (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
